drug development

News

FDA plans to phase out animal testing for antibodies

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

R&D

Defining success for early-stage, small biotech trials

Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.

R&D

Partner Content

6th Cytokine-Based Drug Development Summit 2025

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t

Digital

Balancing innovation and efficiency in clinical trials: Is t...

Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes

R&D

Life Sciences Industry Report - Rare Disease Space

There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.

R&D

Graphic of man with briefcase using large magnifying glass to search for something

Focusing too many R&D resources on one drug: The hidden cost...

Drug development is a high-stakes, high-cost endeavour.